Clinical Trials

LymphoidMyeloidOther hematologic neoplasmPlasma cell

34 enrolled 18 charts

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes

NCT03493945 2025-09-30

Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)

59 enrolled 20 charts

Prostatic Neoplasms

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Phase 2/3 Completed

130 enrolled 8 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT03324113 2025-08-05

Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

34 enrolled

Tumor-Agnostic

Neoplasms

NCT03448393 2025-06-04

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

LymphoidOther hematologic neoplasm

54 enrolled 24 charts

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03554473 2025-05-09

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

37 enrolled 19 charts

Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT03107182 2025-05-06

OPTIMA-II

72 enrolled 14 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01998971 2025-04-25

A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

240 enrolled 1 FDA

Plasma cell

Multiple Myeloma

NCT04599634 2025-02-04

Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies

11 enrolled 16 charts

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03030417 2024-12-10

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

36 enrolled 35 charts

Lymphoma

NCT04580121 2024-06-03

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

Other hematologic neoplasm

59 enrolled

Leukemia, Myeloid, Acute

NCT04660799 2023-10-12

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

50 enrolled 25 charts

Lymphoma, Large B-Cell, Diffuse

NCT04189588 2023-10-06

versus

34 enrolled 11 charts

Oncology Patients Receiving Chemotherapy

NCT03330028 2023-04-21

Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

29 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01392183 2021-09-20

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

69 enrolled 15 charts

BreastGastrointestinalGynecologicHead & NeckThoracic

Pathologic Complete Response, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT04237090 2020-10-12

PREMED-F1

Phase 3 Completed

27 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00185692 2019-12-04

Allogeneic Transplantation From Related Haploidentical Donors

LymphoidOther hematologic neoplasm

16 enrolled 8 charts

Graft vs Host Disease, Hodgkin Disease, Leukemia, Neoplasms, Hematologic Neoplasms

NCT02648490 2019-07-30

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers

19 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01332630 2018-09-20

TPI 287 in Breast Cancer Metastatic to the Brain

24 enrolled 8 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT01985126 2018-06-25

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

124 enrolled 18 charts

Plasma cell

Multiple Myeloma

NCT00186628 2017-11-28

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

LymphoidOther hematologic neoplasm

36 enrolled 12 charts

Leukemia, Mast-Cell, Lymphoma, Mantle-Cell

NCT00899847 2017-10-20

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

9 enrolled 15 charts

Plasma cell

Multiple Myeloma

NCT00923910 2017-04-12

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

LymphoidMyeloidOther hematologic neoplasm

10 enrolled 21 charts

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00490009 2017-03-30

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

9 enrolled 10 charts

Lymphoma

NCT02441894 2017-01-24

PEGAZUS

Phase 4 Completed

21 enrolled

Prostatic Neoplasms

NCT01556932 2015-10-16

Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea

Phase NA Completed

22 enrolled 7 charts

Nausea, Vomiting

NCT01017731 2015-06-10

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

68 enrolled 13 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00515073 2014-07-03

Papillary Serous Carcinoma of the Endometrium

30 enrolled 5 charts

Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT01837446 2013-04-23

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

Phase 2/3 Completed

30 enrolled

Other

Pain, Stomatitis, Mucositis

NCT00030992 2012-08-20

BMS 247550 to Treat Kidney Cancer

102 enrolled 10 charts